High Mobility Group A proteins in esophageal carcinomas

References

• Palumbo Jr A, Meireles Da Costa N, Esposito F, De Martino M, D'Angelo D, de Sousa VP, Martins I, Nasciutti LE, Fusco A, Ribeiro Pinto LF. HMGA2 overexpression plays a critical role in the progression of esophageal squamous carcinoma. Oncotarget 2016; 7:25872-84.
   Google Scholar
• Montgomery EA, Bosman FT, Brennan P, Malekzadeh R. Oesophageal Cancer. In World Cancer Report 2014. World Health Organization; 2014: 528-43.
   Google Scholar
• Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut 2015; 64(3):381-7; PMID:25320104; http://dx.doi.org/10.1136/gutjnl-2014-308124
   PubMed Web of Science ®Google Scholar
• Vizcaino AP, Moreno V, Lambert R, Parkin D M. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries. Int J Cancer 2002; 99(6):860-8
   PubMed Web of Science ®Google Scholar
• Rubenstein JH, Shaheen NJ. Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology (Reviews in Basic and Clinical Gastroenterology and Hepatology) 2015; 149:302-17
   Google Scholar
• Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am J Epidemiol 2008; 168(3):237-49; PMID:18550563; http://dx.doi.org/10.1093/aje/kwn121
   PubMed Web of Science ®Google Scholar
• Sharma P, Marcon N, Wani S, Bansal A, Mathur S, Sampliner R, Lightdale C. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study. Endoscopy 2006; 38(12):1206-12; http://dx.doi.org/10.1055/s-2006-944974
   PubMed Web of Science ®Google Scholar
• Meireles Da Costa NM, Lima SCS, de Almeida Simão T, Ribeiro Pinto LF. The potential of molecular markers to improve interventions through the natural history of oesophageal squamous cell carcinoma. Biosci Rep 2013; 33(4):e00057; PMID:23837802
   PubMed Web of Science ®Google Scholar
• Fusco A, Fedele M. Roles of HMGA proteins in cancer. Nat Rev Cancer 2007; 7:899-910; PMID:18004397; http://dx.doi.org/10.1038/nrc2271
   PubMed Web of Science ®Google Scholar
• Berlingieri MT, Manfioletti G, Santoro M, Bandiera A, Visconti R, Giancotti V, Fusco A. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol 1995; 15:1545-53; PMID:7862147; http://dx.doi.org/10.1128/MCB.15.3.1545
   PubMed Web of Science ®Google Scholar
• Berlingieri MT, Pierantoni GM, Giancotti V, Santoro M, Fusco A. Thyroid cell transformation requires the expression of the HMG1 proteins. Oncogene 2002; 21:2971-80; PMID:12082527; http://dx.doi.org/10.1038/sj.onc.1205368
   PubMed Web of Science ®Google Scholar
• Foti D, Chiefari E, Fedele M, Iuliano R, Brunetti L, Paonessa F, Manfioletti G, Barbetti F, Brunetti A, Croce CM, et al. Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat Med 2005; 11:765-73; PMID:15924147; http://dx.doi.org/10.1038/nm1254
   PubMed Web of Science ®Google Scholar
• Fedele M, Fidanza V, Battista S, Pentimalli F, Klein-Szanto AJ, Visone R, De Martino I, Curcio A, Morisco C, Del Vecchio L, et al. Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res 2006; 66:2536-43; PMID:16510570; http://dx.doi.org/10.1158/0008-5472.CAN-05-1889
   PubMed Web of Science ®Google Scholar
• Zhou X, Benson KF, Ashar HR, Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 1995; 376:771-4; PMID:7651535; http://dx.doi.org/10.1038/376771a0
   PubMed Web of Science ®Google Scholar
• Anand A, Chada K. In vivo modulation of Hmgic reduces obesity. Nat Genet 2000; 24:377-80; PMID:10742101; http://dx.doi.org/10.1038/74207
   PubMed Web of Science ®Google Scholar
• Pallante P, Sepe R, Puca F, Fusco A. High mobility group a proteins as tumor markers. Front Med 2015; 2:15; PMID:25859543; http://dx.doi.org/10.3389/fmed.2015.00015
   PubMedGoogle Scholar
• Gevaert O, Daemen A, De Moor B, Libbrecht L. A taxonomy of epithelial human cancer and their metastases. BMC Med Genomics 2009; 2(1):1; PMID:19128478; http://dx.doi.org/10.1186/1755-8794-2-69
   PubMed Web of Science ®Google Scholar
• Chen X, Lechago J, Ertan A, Ergun G, Verm R, Bridges M, Younes M. Expression of the high mobility group proteins HMGI (Y) correlates with malignant progression in Barrett's metaplasia. Cancer Epidemiol Biomarkers Prev 2004; 13(1):30-33; http://dx.doi.org/10.1158/1055-9965.EPI-03-0151
   PubMed Web of Science ®Google Scholar
• Yap TA, Gerlinger M, Futreal P A, Pusztai L, Swanton C. Intratumor heterogeneity: seeing the wood for the trees. Sci Translati Med 2012; 4(127):10; http://dx.doi.org/10.1126/scitranslmed.3003854
   Web of Science ®Google Scholar
• Cleynen I, Van de Ven WJ. The HMGA proteins: a myriad of functions (Review). Int J Oncol 2008; 32(2):289-305; PMID:18202751
   PubMed Web of Science ®Google Scholar
• Fedele M, Fusco A. HMGA and cancer. Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 2010; 1799(1):48-54; http://dx.doi.org/10.1016/j.bbagrm.2009.11.007
   PubMed Web of Science ®Google Scholar
• Hajian-Tilaki K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Int Med 2013; 4(2):627; PMID:24009950
   PubMedGoogle Scholar
• Galdiero F, Romano A, Pasquinelli R, Pignata S, Greggi S, Vuttariello E, Losito NS. Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer. Oncotarget 2015; 6(22):19328; PMID:25749380; http://dx.doi.org/10.18632/oncotarget.2896
   PubMed Web of Science ®Google Scholar
• Esposito F, De Martino M, Petti MG, Forzati F, Tornincasa M, Federico A, Arra C, Pierantoni GM, Fusco A. HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs. Oncotarget 2014; 5:8341-54; PMID:25268743; http://dx.doi.org/10.18632/oncotarget.2202
   PubMed Web of Science ®Google Scholar
• Esposito F, De Martino M, D'Angelo D, Mussnich P, Raverot G, Jaffrain-Rea ML, Fraggetta F, Trouillas J, Fusco A. HMGA1-pseudogene expression is induced in human pituitary tumors. Cell Cycle 2015; 14:1471-75; PMID:25894544; http://dx.doi.org/10.1080/15384101.2015.1021520
   PubMed Web of Science ®Google Scholar
• Puca F, Colamaio M, Federico A, Gemei M, Tosti N, Bastos AU, Fusco A. HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels. Oncotarget 2014; 5(10):3234-45; PMID:24833610; http://dx.doi.org/10.18632/oncotarget.1914
   PubMed Web of Science ®Google Scholar
• D'Angelo D, Borbone E, Palmieri D, Uboldi S, Esposito F, Frapolli R, Fusco A. The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin. Eur J Cancer 2013; 49(5):1142-51; http://dx.doi.org/10.1016/j.ejca.2012.10.014
   PubMed Web of Science ®Google Scholar